Publications by authors named "Anne-Marie Scheuble"
Complete remission of BRAF V600E-driven ACC CUP by BRAF/MEK inhibition underscores importance of precision oncology.
View Article and Find Full Text PDFArticle Synopsis
- - The ADRISK trial is a study focused on patients with locally advanced head and neck squamous cell carcinoma (HNSCC) who are at high risk of recurrence after surgery.
- - It compares the effectiveness of standard adjuvant radio(chemo)therapy (aRCT) with cisplatin to aRCT combined with pembrolizumab, an immunotherapy drug, in improving event-free survival.
- - The trial involves 240 patients with specific criteria and aims to assess outcomes in terms of event-free and overall survival, with recruitment commencing in August 2018 and still ongoing.